A LONG-AWAITED decision on whether Jersey should provide publicly funded weight-loss drugs has been delayed – a move that a leading campaigner has warned is leaving Islanders with “very limited” treatment options. Confirmation on whether Jersey would follow the UK in allowing doctors providing publicly funded care to prescribe GLP-1 agonists, such as Mounjaro, for […]
Jersey Evening Post
